nodes	percent_of_prediction	percent_of_DWPC	metapath
Lercanidipine—CYP3A4—Thiotepa—urinary bladder cancer	0.0124	0.41	CbGbCtD
Lercanidipine—CYP3A5—Etoposide—urinary bladder cancer	0.00862	0.285	CbGbCtD
Lercanidipine—CYP2D6—Doxorubicin—urinary bladder cancer	0.00361	0.119	CbGbCtD
Lercanidipine—CYP3A4—Etoposide—urinary bladder cancer	0.00336	0.111	CbGbCtD
Lercanidipine—CYP3A4—Doxorubicin—urinary bladder cancer	0.00229	0.0758	CbGbCtD
Lercanidipine—CACNA1D—prostate gland—urinary bladder cancer	0.000783	0.127	CbGeAlD
Lercanidipine—CYP3A4—urine—urinary bladder cancer	0.000743	0.121	CbGeAlD
Lercanidipine—CYP2D6—urine—urinary bladder cancer	0.000731	0.119	CbGeAlD
Lercanidipine—CACNA1C—prostate gland—urinary bladder cancer	0.000723	0.118	CbGeAlD
Lercanidipine—Pollakiuria—Doxorubicin—urinary bladder cancer	0.000666	0.00084	CcSEcCtD
Lercanidipine—Asthenia—Gemcitabine—urinary bladder cancer	0.000664	0.000837	CcSEcCtD
Lercanidipine—CACNA1D—NCAM signaling for neurite out-growth—SRC—urinary bladder cancer	0.00066	0.00388	CbGpPWpGaD
Lercanidipine—Urinary tract disorder—Methotrexate—urinary bladder cancer	0.000658	0.00083	CcSEcCtD
Lercanidipine—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	0.000658	0.00083	CcSEcCtD
Lercanidipine—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.000657	0.000828	CcSEcCtD
Lercanidipine—Pruritus—Gemcitabine—urinary bladder cancer	0.000655	0.000826	CcSEcCtD
Lercanidipine—Nausea—Thiotepa—urinary bladder cancer	0.000654	0.000824	CcSEcCtD
Lercanidipine—Urethral disorder—Methotrexate—urinary bladder cancer	0.000654	0.000823	CcSEcCtD
Lercanidipine—Feeling abnormal—Etoposide—urinary bladder cancer	0.000652	0.000821	CcSEcCtD
Lercanidipine—Agranulocytosis—Epirubicin—urinary bladder cancer	0.000649	0.000817	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000647	0.000815	CcSEcCtD
Lercanidipine—Pruritus—Fluorouracil—urinary bladder cancer	0.000644	0.000812	CcSEcCtD
Lercanidipine—CYP2D6—Biological oxidations—UGT2B7—urinary bladder cancer	0.000644	0.00379	CbGpPWpGaD
Lercanidipine—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.000638	0.000803	CcSEcCtD
Lercanidipine—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000636	0.000801	CcSEcCtD
Lercanidipine—CYP2D6—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000635	0.00374	CbGpPWpGaD
Lercanidipine—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000634	0.000798	CcSEcCtD
Lercanidipine—Renal failure—Doxorubicin—urinary bladder cancer	0.000632	0.000797	CcSEcCtD
Lercanidipine—Erythema multiforme—Methotrexate—urinary bladder cancer	0.00063	0.000794	CcSEcCtD
Lercanidipine—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	0.00063	0.000794	CcSEcCtD
Lercanidipine—Urticaria—Etoposide—urinary bladder cancer	0.000628	0.000792	CcSEcCtD
Lercanidipine—Stomatitis—Doxorubicin—urinary bladder cancer	0.000627	0.00079	CcSEcCtD
Lercanidipine—Jaundice—Doxorubicin—urinary bladder cancer	0.000627	0.00079	CcSEcCtD
Lercanidipine—Rhinitis—Epirubicin—urinary bladder cancer	0.000626	0.000788	CcSEcCtD
Lercanidipine—Body temperature increased—Etoposide—urinary bladder cancer	0.000625	0.000788	CcSEcCtD
Lercanidipine—Abdominal pain—Etoposide—urinary bladder cancer	0.000625	0.000788	CcSEcCtD
Lercanidipine—Hepatitis—Epirubicin—urinary bladder cancer	0.000624	0.000786	CcSEcCtD
Lercanidipine—Eye disorder—Methotrexate—urinary bladder cancer	0.000623	0.000785	CcSEcCtD
Lercanidipine—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000623	0.000785	CcSEcCtD
Lercanidipine—Tinnitus—Methotrexate—urinary bladder cancer	0.000622	0.000783	CcSEcCtD
Lercanidipine—Asthenia—Cisplatin—urinary bladder cancer	0.000619	0.00078	CcSEcCtD
Lercanidipine—Cardiac disorder—Methotrexate—urinary bladder cancer	0.000619	0.00078	CcSEcCtD
Lercanidipine—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.000616	0.000776	CcSEcCtD
Lercanidipine—Oedema peripheral—Epirubicin—urinary bladder cancer	0.000615	0.000774	CcSEcCtD
Lercanidipine—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000613	0.000773	CcSEcCtD
Lercanidipine—Urethral disorder—Epirubicin—urinary bladder cancer	0.000612	0.000771	CcSEcCtD
Lercanidipine—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000608	0.000766	CcSEcCtD
Lercanidipine—Angiopathy—Methotrexate—urinary bladder cancer	0.000605	0.000762	CcSEcCtD
Lercanidipine—Immune system disorder—Methotrexate—urinary bladder cancer	0.000602	0.000759	CcSEcCtD
Lercanidipine—Dizziness—Fluorouracil—urinary bladder cancer	0.000602	0.000759	CcSEcCtD
Lercanidipine—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000601	0.000757	CcSEcCtD
Lercanidipine—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.0006	0.000756	CcSEcCtD
Lercanidipine—CYP3A7—Biological oxidations—HPGDS—urinary bladder cancer	0.0006	0.00353	CbGpPWpGaD
Lercanidipine—Diarrhoea—Cisplatin—urinary bladder cancer	0.000591	0.000744	CcSEcCtD
Lercanidipine—Erythema multiforme—Epirubicin—urinary bladder cancer	0.00059	0.000743	CcSEcCtD
Lercanidipine—Alopecia—Methotrexate—urinary bladder cancer	0.000589	0.000742	CcSEcCtD
Lercanidipine—Vomiting—Gemcitabine—urinary bladder cancer	0.000589	0.000742	CcSEcCtD
Lercanidipine—Mental disorder—Methotrexate—urinary bladder cancer	0.000584	0.000736	CcSEcCtD
Lercanidipine—Rash—Gemcitabine—urinary bladder cancer	0.000584	0.000736	CcSEcCtD
Lercanidipine—Dermatitis—Gemcitabine—urinary bladder cancer	0.000583	0.000735	CcSEcCtD
Lercanidipine—Eye disorder—Epirubicin—urinary bladder cancer	0.000583	0.000735	CcSEcCtD
Lercanidipine—Hypersensitivity—Etoposide—urinary bladder cancer	0.000583	0.000734	CcSEcCtD
Lercanidipine—CYP3A7—Biological oxidations—GSTT1—urinary bladder cancer	0.000582	0.00343	CbGpPWpGaD
Lercanidipine—Tinnitus—Epirubicin—urinary bladder cancer	0.000582	0.000733	CcSEcCtD
Lercanidipine—Erythema—Methotrexate—urinary bladder cancer	0.00058	0.000731	CcSEcCtD
Lercanidipine—Malnutrition—Methotrexate—urinary bladder cancer	0.00058	0.000731	CcSEcCtD
Lercanidipine—Headache—Gemcitabine—urinary bladder cancer	0.00058	0.000731	CcSEcCtD
Lercanidipine—CACNA1C—NCAM signaling for neurite out-growth—SRC—urinary bladder cancer	0.00058	0.00341	CbGpPWpGaD
Lercanidipine—CYP2D6—Biological oxidations—CYP4B1—urinary bladder cancer	0.00058	0.00341	CbGpPWpGaD
Lercanidipine—Flushing—Epirubicin—urinary bladder cancer	0.000579	0.00073	CcSEcCtD
Lercanidipine—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000579	0.00073	CcSEcCtD
Lercanidipine—Vomiting—Fluorouracil—urinary bladder cancer	0.000579	0.000729	CcSEcCtD
Lercanidipine—Rhinitis—Doxorubicin—urinary bladder cancer	0.000579	0.000729	CcSEcCtD
Lercanidipine—Hepatitis—Doxorubicin—urinary bladder cancer	0.000577	0.000727	CcSEcCtD
Lercanidipine—Rash—Fluorouracil—urinary bladder cancer	0.000574	0.000723	CcSEcCtD
Lercanidipine—Dermatitis—Fluorouracil—urinary bladder cancer	0.000574	0.000723	CcSEcCtD
Lercanidipine—CYP2D6—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000572	0.00337	CbGpPWpGaD
Lercanidipine—Headache—Fluorouracil—urinary bladder cancer	0.00057	0.000719	CcSEcCtD
Lercanidipine—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.00057	0.000718	CcSEcCtD
Lercanidipine—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000569	0.000717	CcSEcCtD
Lercanidipine—Dysgeusia—Methotrexate—urinary bladder cancer	0.000568	0.000716	CcSEcCtD
Lercanidipine—Asthenia—Etoposide—urinary bladder cancer	0.000567	0.000715	CcSEcCtD
Lercanidipine—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.000567	0.000715	CcSEcCtD
Lercanidipine—Angiopathy—Epirubicin—urinary bladder cancer	0.000566	0.000713	CcSEcCtD
Lercanidipine—Urethral disorder—Doxorubicin—urinary bladder cancer	0.000566	0.000713	CcSEcCtD
Lercanidipine—Immune system disorder—Epirubicin—urinary bladder cancer	0.000564	0.00071	CcSEcCtD
Lercanidipine—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000562	0.000709	CcSEcCtD
Lercanidipine—Pruritus—Etoposide—urinary bladder cancer	0.00056	0.000705	CcSEcCtD
Lercanidipine—Alopecia—Epirubicin—urinary bladder cancer	0.000551	0.000695	CcSEcCtD
Lercanidipine—Nausea—Gemcitabine—urinary bladder cancer	0.00055	0.000693	CcSEcCtD
Lercanidipine—Vomiting—Cisplatin—urinary bladder cancer	0.000549	0.000692	CcSEcCtD
Lercanidipine—Vision blurred—Methotrexate—urinary bladder cancer	0.000547	0.000689	CcSEcCtD
Lercanidipine—Mental disorder—Epirubicin—urinary bladder cancer	0.000547	0.000689	CcSEcCtD
Lercanidipine—CACNA1D—NCAM signaling for neurite out-growth—KRAS—urinary bladder cancer	0.000546	0.00322	CbGpPWpGaD
Lercanidipine—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000546	0.000688	CcSEcCtD
Lercanidipine—Rash—Cisplatin—urinary bladder cancer	0.000544	0.000686	CcSEcCtD
Lercanidipine—Dermatitis—Cisplatin—urinary bladder cancer	0.000544	0.000685	CcSEcCtD
Lercanidipine—Malnutrition—Epirubicin—urinary bladder cancer	0.000543	0.000684	CcSEcCtD
Lercanidipine—Erythema—Epirubicin—urinary bladder cancer	0.000543	0.000684	CcSEcCtD
Lercanidipine—CYP3A5—Biological oxidations—NAT2—urinary bladder cancer	0.000543	0.00319	CbGpPWpGaD
Lercanidipine—Diarrhoea—Etoposide—urinary bladder cancer	0.000541	0.000682	CcSEcCtD
Lercanidipine—Nausea—Fluorouracil—urinary bladder cancer	0.000541	0.000681	CcSEcCtD
Lercanidipine—Eye disorder—Doxorubicin—urinary bladder cancer	0.00054	0.00068	CcSEcCtD
Lercanidipine—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000539	0.000678	CcSEcCtD
Lercanidipine—Tinnitus—Doxorubicin—urinary bladder cancer	0.000538	0.000678	CcSEcCtD
Lercanidipine—Anaemia—Methotrexate—urinary bladder cancer	0.000536	0.000676	CcSEcCtD
Lercanidipine—Flushing—Doxorubicin—urinary bladder cancer	0.000536	0.000675	CcSEcCtD
Lercanidipine—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000536	0.000675	CcSEcCtD
Lercanidipine—CYP3A5—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000535	0.00315	CbGpPWpGaD
Lercanidipine—Tension—Epirubicin—urinary bladder cancer	0.000533	0.000672	CcSEcCtD
Lercanidipine—Dysgeusia—Epirubicin—urinary bladder cancer	0.000532	0.00067	CcSEcCtD
Lercanidipine—Nervousness—Epirubicin—urinary bladder cancer	0.000528	0.000665	CcSEcCtD
Lercanidipine—Angiopathy—Doxorubicin—urinary bladder cancer	0.000524	0.00066	CcSEcCtD
Lercanidipine—Malaise—Methotrexate—urinary bladder cancer	0.000523	0.000659	CcSEcCtD
Lercanidipine—Dizziness—Etoposide—urinary bladder cancer	0.000523	0.000659	CcSEcCtD
Lercanidipine—Muscle spasms—Epirubicin—urinary bladder cancer	0.000522	0.000658	CcSEcCtD
Lercanidipine—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000521	0.000657	CcSEcCtD
Lercanidipine—Vertigo—Methotrexate—urinary bladder cancer	0.000521	0.000657	CcSEcCtD
Lercanidipine—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.00052	0.000656	CcSEcCtD
Lercanidipine—Nausea—Cisplatin—urinary bladder cancer	0.000513	0.000646	CcSEcCtD
Lercanidipine—Vision blurred—Epirubicin—urinary bladder cancer	0.000512	0.000645	CcSEcCtD
Lercanidipine—CACNA1C—smooth muscle tissue—urinary bladder cancer	0.000512	0.0833	CbGeAlD
Lercanidipine—Alopecia—Doxorubicin—urinary bladder cancer	0.00051	0.000643	CcSEcCtD
Lercanidipine—Cough—Methotrexate—urinary bladder cancer	0.000506	0.000638	CcSEcCtD
Lercanidipine—Mental disorder—Doxorubicin—urinary bladder cancer	0.000506	0.000637	CcSEcCtD
Lercanidipine—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000504	0.000635	CcSEcCtD
Lercanidipine—Vomiting—Etoposide—urinary bladder cancer	0.000503	0.000634	CcSEcCtD
Lercanidipine—Malnutrition—Doxorubicin—urinary bladder cancer	0.000503	0.000633	CcSEcCtD
Lercanidipine—Erythema—Doxorubicin—urinary bladder cancer	0.000503	0.000633	CcSEcCtD
Lercanidipine—Anaemia—Epirubicin—urinary bladder cancer	0.000502	0.000633	CcSEcCtD
Lercanidipine—Rash—Etoposide—urinary bladder cancer	0.000499	0.000628	CcSEcCtD
Lercanidipine—Dermatitis—Etoposide—urinary bladder cancer	0.000498	0.000628	CcSEcCtD
Lercanidipine—Headache—Etoposide—urinary bladder cancer	0.000495	0.000624	CcSEcCtD
Lercanidipine—Arthralgia—Methotrexate—urinary bladder cancer	0.000494	0.000623	CcSEcCtD
Lercanidipine—Chest pain—Methotrexate—urinary bladder cancer	0.000494	0.000623	CcSEcCtD
Lercanidipine—Myalgia—Methotrexate—urinary bladder cancer	0.000494	0.000623	CcSEcCtD
Lercanidipine—Tension—Doxorubicin—urinary bladder cancer	0.000493	0.000621	CcSEcCtD
Lercanidipine—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000492	0.00062	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000491	0.000618	CcSEcCtD
Lercanidipine—Malaise—Epirubicin—urinary bladder cancer	0.00049	0.000617	CcSEcCtD
Lercanidipine—CACNA1D—Alzheimers Disease—TNF—urinary bladder cancer	0.000489	0.00288	CbGpPWpGaD
Lercanidipine—Discomfort—Methotrexate—urinary bladder cancer	0.000488	0.000615	CcSEcCtD
Lercanidipine—Nervousness—Doxorubicin—urinary bladder cancer	0.000488	0.000615	CcSEcCtD
Lercanidipine—Vertigo—Epirubicin—urinary bladder cancer	0.000488	0.000615	CcSEcCtD
Lercanidipine—Syncope—Epirubicin—urinary bladder cancer	0.000487	0.000614	CcSEcCtD
Lercanidipine—CYP3A4—Biological oxidations—GSTZ1—urinary bladder cancer	0.000486	0.00286	CbGpPWpGaD
Lercanidipine—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000483	0.000609	CcSEcCtD
Lercanidipine—CACNA1C—NCAM signaling for neurite out-growth—KRAS—urinary bladder cancer	0.00048	0.00283	CbGpPWpGaD
Lercanidipine—Palpitations—Epirubicin—urinary bladder cancer	0.00048	0.000605	CcSEcCtD
Lercanidipine—CYP3A4—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.000479	0.00282	CbGpPWpGaD
Lercanidipine—Confusional state—Methotrexate—urinary bladder cancer	0.000478	0.000602	CcSEcCtD
Lercanidipine—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000477	0.000601	CcSEcCtD
Lercanidipine—Cough—Epirubicin—urinary bladder cancer	0.000474	0.000597	CcSEcCtD
Lercanidipine—Vision blurred—Doxorubicin—urinary bladder cancer	0.000474	0.000597	CcSEcCtD
Lercanidipine—Nausea—Etoposide—urinary bladder cancer	0.00047	0.000592	CcSEcCtD
Lercanidipine—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000466	0.000588	CcSEcCtD
Lercanidipine—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000465	0.000585	CcSEcCtD
Lercanidipine—Anaemia—Doxorubicin—urinary bladder cancer	0.000465	0.000585	CcSEcCtD
Lercanidipine—CACNA1D—NCAM signaling for neurite out-growth—HRAS—urinary bladder cancer	0.000464	0.00273	CbGpPWpGaD
Lercanidipine—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000464	0.000584	CcSEcCtD
Lercanidipine—Myalgia—Epirubicin—urinary bladder cancer	0.000462	0.000583	CcSEcCtD
Lercanidipine—Chest pain—Epirubicin—urinary bladder cancer	0.000462	0.000583	CcSEcCtD
Lercanidipine—Arthralgia—Epirubicin—urinary bladder cancer	0.000462	0.000583	CcSEcCtD
Lercanidipine—Anxiety—Epirubicin—urinary bladder cancer	0.000461	0.000581	CcSEcCtD
Lercanidipine—CYP3A4—Biological oxidations—GSTO2—urinary bladder cancer	0.00046	0.00271	CbGpPWpGaD
Lercanidipine—CYP3A4—Biological oxidations—NAT1—urinary bladder cancer	0.00046	0.00271	CbGpPWpGaD
Lercanidipine—Skin disorder—Methotrexate—urinary bladder cancer	0.00046	0.00058	CcSEcCtD
Lercanidipine—CACNA1D—Metabolism—GSTZ1—urinary bladder cancer	0.000459	0.0027	CbGpPWpGaD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000459	0.000579	CcSEcCtD
Lercanidipine—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000458	0.000577	CcSEcCtD
Lercanidipine—Discomfort—Epirubicin—urinary bladder cancer	0.000457	0.000576	CcSEcCtD
Lercanidipine—CYP3A4—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000454	0.00267	CbGpPWpGaD
Lercanidipine—Malaise—Doxorubicin—urinary bladder cancer	0.000453	0.000571	CcSEcCtD
Lercanidipine—Dry mouth—Epirubicin—urinary bladder cancer	0.000452	0.00057	CcSEcCtD
Lercanidipine—Vertigo—Doxorubicin—urinary bladder cancer	0.000452	0.000569	CcSEcCtD
Lercanidipine—Anorexia—Methotrexate—urinary bladder cancer	0.000452	0.000569	CcSEcCtD
Lercanidipine—Syncope—Doxorubicin—urinary bladder cancer	0.000451	0.000568	CcSEcCtD
Lercanidipine—Confusional state—Epirubicin—urinary bladder cancer	0.000447	0.000563	CcSEcCtD
Lercanidipine—Palpitations—Doxorubicin—urinary bladder cancer	0.000444	0.00056	CcSEcCtD
Lercanidipine—Hypotension—Methotrexate—urinary bladder cancer	0.000443	0.000558	CcSEcCtD
Lercanidipine—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000442	0.000557	CcSEcCtD
Lercanidipine—Cough—Doxorubicin—urinary bladder cancer	0.000439	0.000553	CcSEcCtD
Lercanidipine—Shock—Epirubicin—urinary bladder cancer	0.000436	0.000549	CcSEcCtD
Lercanidipine—CACNA1D—Metabolism—GSTO2—urinary bladder cancer	0.000435	0.00256	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—NAT1—urinary bladder cancer	0.000435	0.00256	CbGpPWpGaD
Lercanidipine—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000435	0.000548	CcSEcCtD
Lercanidipine—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000434	0.000547	CcSEcCtD
Lercanidipine—CYP3A5—Biological oxidations—HPGDS—urinary bladder cancer	0.000434	0.00255	CbGpPWpGaD
Lercanidipine—Tachycardia—Epirubicin—urinary bladder cancer	0.000433	0.000545	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000432	0.000544	CcSEcCtD
Lercanidipine—CACNA1D—Alzheimers Disease—TP53—urinary bladder cancer	0.000431	0.00254	CbGpPWpGaD
Lercanidipine—Skin disorder—Epirubicin—urinary bladder cancer	0.000431	0.000543	CcSEcCtD
Lercanidipine—CACNA1C—Alzheimers Disease—TNF—urinary bladder cancer	0.000429	0.00253	CbGpPWpGaD
Lercanidipine—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000429	0.00054	CcSEcCtD
Lercanidipine—Insomnia—Methotrexate—urinary bladder cancer	0.000428	0.00054	CcSEcCtD
Lercanidipine—Arthralgia—Doxorubicin—urinary bladder cancer	0.000428	0.000539	CcSEcCtD
Lercanidipine—Myalgia—Doxorubicin—urinary bladder cancer	0.000428	0.000539	CcSEcCtD
Lercanidipine—Chest pain—Doxorubicin—urinary bladder cancer	0.000428	0.000539	CcSEcCtD
Lercanidipine—Anxiety—Doxorubicin—urinary bladder cancer	0.000426	0.000537	CcSEcCtD
Lercanidipine—Paraesthesia—Methotrexate—urinary bladder cancer	0.000425	0.000536	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000425	0.000535	CcSEcCtD
Lercanidipine—Discomfort—Doxorubicin—urinary bladder cancer	0.000423	0.000533	CcSEcCtD
Lercanidipine—Anorexia—Epirubicin—urinary bladder cancer	0.000423	0.000532	CcSEcCtD
Lercanidipine—Dyspnoea—Methotrexate—urinary bladder cancer	0.000422	0.000532	CcSEcCtD
Lercanidipine—Somnolence—Methotrexate—urinary bladder cancer	0.000421	0.000531	CcSEcCtD
Lercanidipine—CYP3A4—Biological oxidations—UGT2B7—urinary bladder cancer	0.000421	0.00248	CbGpPWpGaD
Lercanidipine—CYP3A5—Biological oxidations—GSTT1—urinary bladder cancer	0.000421	0.00248	CbGpPWpGaD
Lercanidipine—Dry mouth—Doxorubicin—urinary bladder cancer	0.000418	0.000527	CcSEcCtD
Lercanidipine—Dyspepsia—Methotrexate—urinary bladder cancer	0.000417	0.000525	CcSEcCtD
Lercanidipine—CYP3A4—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000415	0.00244	CbGpPWpGaD
Lercanidipine—Hypotension—Epirubicin—urinary bladder cancer	0.000414	0.000522	CcSEcCtD
Lercanidipine—Confusional state—Doxorubicin—urinary bladder cancer	0.000414	0.000521	CcSEcCtD
Lercanidipine—Decreased appetite—Methotrexate—urinary bladder cancer	0.000412	0.000519	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000409	0.000515	CcSEcCtD
Lercanidipine—Fatigue—Methotrexate—urinary bladder cancer	0.000408	0.000515	CcSEcCtD
Lercanidipine—CACNA1C—NCAM signaling for neurite out-growth—HRAS—urinary bladder cancer	0.000408	0.0024	CbGpPWpGaD
Lercanidipine—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000404	0.000509	CcSEcCtD
Lercanidipine—CACNA1C—Metabolism—GSTZ1—urinary bladder cancer	0.000404	0.00238	CbGpPWpGaD
Lercanidipine—Shock—Doxorubicin—urinary bladder cancer	0.000404	0.000508	CcSEcCtD
Lercanidipine—CYP3A7—Biological oxidations—GSTP1—urinary bladder cancer	0.000403	0.00237	CbGpPWpGaD
Lercanidipine—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000402	0.000507	CcSEcCtD
Lercanidipine—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000402	0.000506	CcSEcCtD
Lercanidipine—Insomnia—Epirubicin—urinary bladder cancer	0.000401	0.000505	CcSEcCtD
Lercanidipine—Tachycardia—Doxorubicin—urinary bladder cancer	0.0004	0.000504	CcSEcCtD
Lercanidipine—Skin disorder—Doxorubicin—urinary bladder cancer	0.000398	0.000502	CcSEcCtD
Lercanidipine—CACNA1D—Metabolism—UGT2B7—urinary bladder cancer	0.000398	0.00234	CbGpPWpGaD
Lercanidipine—Paraesthesia—Epirubicin—urinary bladder cancer	0.000398	0.000502	CcSEcCtD
Lercanidipine—CYP3A7—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000398	0.00234	CbGpPWpGaD
Lercanidipine—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000397	0.0005	CcSEcCtD
Lercanidipine—Dyspnoea—Epirubicin—urinary bladder cancer	0.000395	0.000498	CcSEcCtD
Lercanidipine—CACNA1C—female reproductive system—urinary bladder cancer	0.000394	0.0642	CbGeAlD
Lercanidipine—Somnolence—Epirubicin—urinary bladder cancer	0.000394	0.000497	CcSEcCtD
Lercanidipine—Anorexia—Doxorubicin—urinary bladder cancer	0.000391	0.000493	CcSEcCtD
Lercanidipine—Feeling abnormal—Methotrexate—urinary bladder cancer	0.00039	0.000492	CcSEcCtD
Lercanidipine—Dyspepsia—Epirubicin—urinary bladder cancer	0.00039	0.000492	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000387	0.000488	CcSEcCtD
Lercanidipine—CYP2D6—Biological oxidations—NAT2—urinary bladder cancer	0.000386	0.00227	CbGpPWpGaD
Lercanidipine—Decreased appetite—Epirubicin—urinary bladder cancer	0.000385	0.000486	CcSEcCtD
Lercanidipine—Hypotension—Doxorubicin—urinary bladder cancer	0.000383	0.000483	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000383	0.000482	CcSEcCtD
Lercanidipine—CACNA1C—Metabolism—GSTO2—urinary bladder cancer	0.000383	0.00225	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—NAT1—urinary bladder cancer	0.000383	0.00225	CbGpPWpGaD
Lercanidipine—Fatigue—Epirubicin—urinary bladder cancer	0.000382	0.000482	CcSEcCtD
Lercanidipine—CYP2D6—Metapathway biotransformation—NAT2—urinary bladder cancer	0.00038	0.00224	CbGpPWpGaD
Lercanidipine—CYP3A4—Biological oxidations—CYP4B1—urinary bladder cancer	0.000379	0.00223	CbGpPWpGaD
Lercanidipine—Constipation—Epirubicin—urinary bladder cancer	0.000379	0.000478	CcSEcCtD
Lercanidipine—CACNA1C—Alzheimers Disease—TP53—urinary bladder cancer	0.000379	0.00223	CbGpPWpGaD
Lercanidipine—Urticaria—Methotrexate—urinary bladder cancer	0.000376	0.000474	CcSEcCtD
Lercanidipine—Abdominal pain—Methotrexate—urinary bladder cancer	0.000374	0.000472	CcSEcCtD
Lercanidipine—Body temperature increased—Methotrexate—urinary bladder cancer	0.000374	0.000472	CcSEcCtD
Lercanidipine—CYP3A4—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000374	0.0022	CbGpPWpGaD
Lercanidipine—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000374	0.000471	CcSEcCtD
Lercanidipine—Insomnia—Doxorubicin—urinary bladder cancer	0.000371	0.000467	CcSEcCtD
Lercanidipine—CYP3A7—Biological oxidations—GSTM1—urinary bladder cancer	0.000371	0.00218	CbGpPWpGaD
Lercanidipine—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000368	0.000464	CcSEcCtD
Lercanidipine—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000366	0.000461	CcSEcCtD
Lercanidipine—CYP3A7—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000366	0.00215	CbGpPWpGaD
Lercanidipine—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000365	0.00046	CcSEcCtD
Lercanidipine—Somnolence—Doxorubicin—urinary bladder cancer	0.000365	0.000459	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000362	0.000457	CcSEcCtD
Lercanidipine—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000361	0.000455	CcSEcCtD
Lercanidipine—CACNA1D—Metabolism—CYP4B1—urinary bladder cancer	0.000359	0.00211	CbGpPWpGaD
Lercanidipine—CACNA1C—vagina—urinary bladder cancer	0.000357	0.058	CbGeAlD
Lercanidipine—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000357	0.000449	CcSEcCtD
Lercanidipine—CYP3A5—prostate gland—urinary bladder cancer	0.000356	0.0579	CbGeAlD
Lercanidipine—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000354	0.000446	CcSEcCtD
Lercanidipine—Fatigue—Doxorubicin—urinary bladder cancer	0.000354	0.000446	CcSEcCtD
Lercanidipine—Urticaria—Epirubicin—urinary bladder cancer	0.000352	0.000444	CcSEcCtD
Lercanidipine—Constipation—Doxorubicin—urinary bladder cancer	0.000351	0.000442	CcSEcCtD
Lercanidipine—Abdominal pain—Epirubicin—urinary bladder cancer	0.00035	0.000442	CcSEcCtD
Lercanidipine—Body temperature increased—Epirubicin—urinary bladder cancer	0.00035	0.000442	CcSEcCtD
Lercanidipine—CACNA1C—Metabolism—UGT2B7—urinary bladder cancer	0.00035	0.00206	CbGpPWpGaD
Lercanidipine—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000349	0.00044	CcSEcCtD
Lercanidipine—Asthenia—Methotrexate—urinary bladder cancer	0.00034	0.000428	CcSEcCtD
Lercanidipine—CACNA1D—Metabolism—SLC19A1—urinary bladder cancer	0.000339	0.00199	CbGpPWpGaD
Lercanidipine—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000338	0.000426	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000335	0.000423	CcSEcCtD
Lercanidipine—Pruritus—Methotrexate—urinary bladder cancer	0.000335	0.000422	CcSEcCtD
Lercanidipine—CACNA1D—Metabolism—PRSS3—urinary bladder cancer	0.00033	0.00194	CbGpPWpGaD
Lercanidipine—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000327	0.000411	CcSEcCtD
Lercanidipine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000327	0.00192	CbGpPWpGaD
Lercanidipine—Urticaria—Doxorubicin—urinary bladder cancer	0.000326	0.000411	CcSEcCtD
Lercanidipine—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000324	0.000409	CcSEcCtD
Lercanidipine—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000324	0.000409	CcSEcCtD
Lercanidipine—Diarrhoea—Methotrexate—urinary bladder cancer	0.000324	0.000408	CcSEcCtD
Lercanidipine—Asthenia—Epirubicin—urinary bladder cancer	0.000318	0.000401	CcSEcCtD
Lercanidipine—CACNA1C—Metabolism—CYP4B1—urinary bladder cancer	0.000315	0.00185	CbGpPWpGaD
Lercanidipine—Pruritus—Epirubicin—urinary bladder cancer	0.000314	0.000395	CcSEcCtD
Lercanidipine—Dizziness—Methotrexate—urinary bladder cancer	0.000313	0.000395	CcSEcCtD
Lercanidipine—CYP2D6—Biological oxidations—HPGDS—urinary bladder cancer	0.000308	0.00182	CbGpPWpGaD
Lercanidipine—Diarrhoea—Epirubicin—urinary bladder cancer	0.000303	0.000382	CcSEcCtD
Lercanidipine—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000302	0.000381	CcSEcCtD
Lercanidipine—Vomiting—Methotrexate—urinary bladder cancer	0.000301	0.000379	CcSEcCtD
Lercanidipine—CYP2D6—Biological oxidations—GSTT1—urinary bladder cancer	0.000299	0.00176	CbGpPWpGaD
Lercanidipine—Rash—Methotrexate—urinary bladder cancer	0.000299	0.000376	CcSEcCtD
Lercanidipine—Dermatitis—Methotrexate—urinary bladder cancer	0.000298	0.000376	CcSEcCtD
Lercanidipine—CACNA1C—Metabolism—SLC19A1—urinary bladder cancer	0.000298	0.00175	CbGpPWpGaD
Lercanidipine—Headache—Methotrexate—urinary bladder cancer	0.000297	0.000374	CcSEcCtD
Lercanidipine—CACNA1D—Developmental Biology—NCOR1—urinary bladder cancer	0.000296	0.00174	CbGpPWpGaD
Lercanidipine—Asthenia—Doxorubicin—urinary bladder cancer	0.000294	0.000371	CcSEcCtD
Lercanidipine—Dizziness—Epirubicin—urinary bladder cancer	0.000293	0.000369	CcSEcCtD
Lercanidipine—CYP3A5—Biological oxidations—GSTP1—urinary bladder cancer	0.000292	0.00172	CbGpPWpGaD
Lercanidipine—Pruritus—Doxorubicin—urinary bladder cancer	0.00029	0.000366	CcSEcCtD
Lercanidipine—CACNA1C—Metabolism—PRSS3—urinary bladder cancer	0.00029	0.00171	CbGpPWpGaD
Lercanidipine—CYP3A5—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000288	0.00169	CbGpPWpGaD
Lercanidipine—Vomiting—Epirubicin—urinary bladder cancer	0.000282	0.000355	CcSEcCtD
Lercanidipine—Nausea—Methotrexate—urinary bladder cancer	0.000281	0.000355	CcSEcCtD
Lercanidipine—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000281	0.000354	CcSEcCtD
Lercanidipine—Rash—Epirubicin—urinary bladder cancer	0.00028	0.000352	CcSEcCtD
Lercanidipine—Dermatitis—Epirubicin—urinary bladder cancer	0.000279	0.000352	CcSEcCtD
Lercanidipine—Headache—Epirubicin—urinary bladder cancer	0.000278	0.00035	CcSEcCtD
Lercanidipine—Dizziness—Doxorubicin—urinary bladder cancer	0.000271	0.000342	CcSEcCtD
Lercanidipine—CYP3A5—Biological oxidations—GSTM1—urinary bladder cancer	0.000268	0.00158	CbGpPWpGaD
Lercanidipine—CYP3A5—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000264	0.00156	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—TYMP—urinary bladder cancer	0.000264	0.00155	CbGpPWpGaD
Lercanidipine—Nausea—Epirubicin—urinary bladder cancer	0.000263	0.000332	CcSEcCtD
Lercanidipine—Vomiting—Doxorubicin—urinary bladder cancer	0.000261	0.000329	CcSEcCtD
Lercanidipine—CACNA1C—Developmental Biology—NCOR1—urinary bladder cancer	0.00026	0.00153	CbGpPWpGaD
Lercanidipine—Rash—Doxorubicin—urinary bladder cancer	0.000259	0.000326	CcSEcCtD
Lercanidipine—CACNA1D—Axon guidance—RHOA—urinary bladder cancer	0.000259	0.00152	CbGpPWpGaD
Lercanidipine—Dermatitis—Doxorubicin—urinary bladder cancer	0.000258	0.000326	CcSEcCtD
Lercanidipine—Headache—Doxorubicin—urinary bladder cancer	0.000257	0.000324	CcSEcCtD
Lercanidipine—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	0.000252	0.00148	CbGpPWpGaD
Lercanidipine—CACNA1D—lymph node—urinary bladder cancer	0.00025	0.0407	CbGeAlD
Lercanidipine—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000249	0.00146	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—GSTZ1—urinary bladder cancer	0.000247	0.00145	CbGpPWpGaD
Lercanidipine—Nausea—Doxorubicin—urinary bladder cancer	0.000244	0.000307	CcSEcCtD
Lercanidipine—CYP3A5—renal system—urinary bladder cancer	0.000242	0.0394	CbGeAlD
Lercanidipine—CACNA1D—Axon guidance—ERBB2—urinary bladder cancer	0.000239	0.00141	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—NAT2—urinary bladder cancer	0.000239	0.0014	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—GSTO2—urinary bladder cancer	0.000234	0.00138	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—NAT1—urinary bladder cancer	0.000234	0.00138	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—CDK4—urinary bladder cancer	0.000234	0.00138	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—TYMP—urinary bladder cancer	0.000232	0.00136	CbGpPWpGaD
Lercanidipine—CACNA1C—lymph node—urinary bladder cancer	0.000231	0.0375	CbGeAlD
Lercanidipine—CACNA1C—Axon guidance—RHOA—urinary bladder cancer	0.000227	0.00134	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—UGT2B7—urinary bladder cancer	0.000214	0.00126	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—PPARG—urinary bladder cancer	0.000212	0.00125	CbGpPWpGaD
Lercanidipine—CACNA1C—Axon guidance—ERBB2—urinary bladder cancer	0.00021	0.00124	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—NAT2—urinary bladder cancer	0.00021	0.00123	CbGpPWpGaD
Lercanidipine—CYP2D6—Biological oxidations—GSTP1—urinary bladder cancer	0.000207	0.00122	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—RRM2—urinary bladder cancer	0.000206	0.00121	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—CDK4—urinary bladder cancer	0.000205	0.00121	CbGpPWpGaD
Lercanidipine—CACNA1D—Axon guidance—MMP9—urinary bladder cancer	0.000205	0.00121	CbGpPWpGaD
Lercanidipine—CYP2D6—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000204	0.0012	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—CREBBP—urinary bladder cancer	0.000204	0.0012	CbGpPWpGaD
Lercanidipine—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	0.000202	0.00119	CbGpPWpGaD
Lercanidipine—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	0.000196	0.00115	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—CYP4B1—urinary bladder cancer	0.000193	0.00114	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—HPGDS—urinary bladder cancer	0.000191	0.00112	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—ENO2—urinary bladder cancer	0.000191	0.00112	CbGpPWpGaD
Lercanidipine—CYP2D6—Biological oxidations—GSTM1—urinary bladder cancer	0.000191	0.00112	CbGpPWpGaD
Lercanidipine—CACNA1D—Axon guidance—SRC—urinary bladder cancer	0.000189	0.00111	CbGpPWpGaD
Lercanidipine—CYP2D6—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000188	0.00111	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—PPARG—urinary bladder cancer	0.000187	0.0011	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—GSTT1—urinary bladder cancer	0.000185	0.00109	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—RHOA—urinary bladder cancer	0.000184	0.00109	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—SLC19A1—urinary bladder cancer	0.000182	0.00107	CbGpPWpGaD
Lercanidipine—CYP3A4—renal system—urinary bladder cancer	0.000182	0.0296	CbGeAlD
Lercanidipine—CACNA1C—Metabolism—RRM2—urinary bladder cancer	0.000181	0.00107	CbGpPWpGaD
Lercanidipine—CACNA1C—Axon guidance—MMP9—urinary bladder cancer	0.00018	0.00106	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—CREBBP—urinary bladder cancer	0.000179	0.00105	CbGpPWpGaD
Lercanidipine—CYP2D6—renal system—urinary bladder cancer	0.000179	0.0291	CbGeAlD
Lercanidipine—CYP3A5—Metabolism—GSTZ1—urinary bladder cancer	0.000179	0.00105	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—PRSS3—urinary bladder cancer	0.000178	0.00105	CbGpPWpGaD
Lercanidipine—CYP3A5—vagina—urinary bladder cancer	0.000176	0.0286	CbGeAlD
Lercanidipine—CACNA1D—Developmental Biology—ERBB2—urinary bladder cancer	0.000171	0.00101	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—GSTO2—urinary bladder cancer	0.000169	0.000997	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—NAT1—urinary bladder cancer	0.000169	0.000997	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—ENO2—urinary bladder cancer	0.000168	0.000986	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—HPGDS—urinary bladder cancer	0.000168	0.000986	CbGpPWpGaD
Lercanidipine—CACNA1C—Axon guidance—SRC—urinary bladder cancer	0.000166	0.000979	CbGpPWpGaD
Lercanidipine—CACNA1D—Axon guidance—EGFR—urinary bladder cancer	0.000166	0.000977	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—GSTT1—urinary bladder cancer	0.000163	0.000957	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—RHOA—urinary bladder cancer	0.000162	0.000954	CbGpPWpGaD
Lercanidipine—CACNA1D—Axon guidance—KRAS—urinary bladder cancer	0.000157	0.000923	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—UGT2B7—urinary bladder cancer	0.000155	0.000912	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—NQO1—urinary bladder cancer	0.000154	0.000905	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—ERBB2—urinary bladder cancer	0.00015	0.000883	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—MMP9—urinary bladder cancer	0.000146	0.000862	CbGpPWpGaD
Lercanidipine—CACNA1C—Axon guidance—EGFR—urinary bladder cancer	0.000146	0.000858	CbGpPWpGaD
Lercanidipine—CYP3A4—female reproductive system—urinary bladder cancer	0.000146	0.0237	CbGeAlD
Lercanidipine—CYP2D6—female reproductive system—urinary bladder cancer	0.000143	0.0233	CbGeAlD
Lercanidipine—CYP3A7—Metabolism—TYMP—urinary bladder cancer	0.000142	0.000835	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—CYP4B1—urinary bladder cancer	0.000139	0.000821	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—EP300—urinary bladder cancer	0.000139	0.000818	CbGpPWpGaD
Lercanidipine—CACNA1C—Axon guidance—KRAS—urinary bladder cancer	0.000138	0.000811	CbGpPWpGaD
Lercanidipine—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	0.000136	0.000798	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—NQO1—urinary bladder cancer	0.000135	0.000795	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—SRC—urinary bladder cancer	0.000135	0.000795	CbGpPWpGaD
Lercanidipine—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000134	0.000787	CbGpPWpGaD
Lercanidipine—CACNA1D—Axon guidance—HRAS—urinary bladder cancer	0.000133	0.000784	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—SLC19A1—urinary bladder cancer	0.000132	0.000775	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—MMP9—urinary bladder cancer	0.000129	0.000758	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—NAT2—urinary bladder cancer	0.000128	0.000756	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—PRSS3—urinary bladder cancer	0.000128	0.000755	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—GSTP1—urinary bladder cancer	0.000128	0.000755	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—GSTZ1—urinary bladder cancer	0.000127	0.000748	CbGpPWpGaD
Lercanidipine—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	0.000125	0.000733	CbGpPWpGaD
Lercanidipine—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000123	0.000723	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—EP300—urinary bladder cancer	0.000122	0.000718	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—GSTO2—urinary bladder cancer	0.00012	0.000709	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—NAT1—urinary bladder cancer	0.00012	0.000709	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—TYMS—urinary bladder cancer	0.000119	0.000702	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—SRC—urinary bladder cancer	0.000119	0.000699	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—EGFR—urinary bladder cancer	0.000118	0.000697	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—NCOR1—urinary bladder cancer	0.000118	0.000694	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—GSTM1—urinary bladder cancer	0.000118	0.000694	CbGpPWpGaD
Lercanidipine—CACNA1C—Axon guidance—HRAS—urinary bladder cancer	0.000117	0.000689	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—GPX1—urinary bladder cancer	0.000113	0.000664	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—TNF—urinary bladder cancer	0.000113	0.000664	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—GSTP1—urinary bladder cancer	0.000113	0.000663	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—KRAS—urinary bladder cancer	0.000112	0.000658	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—RRM2—urinary bladder cancer	0.000111	0.000652	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—ERCC2—urinary bladder cancer	0.000111	0.000652	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—UGT2B7—urinary bladder cancer	0.00011	0.000648	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—TYMS—urinary bladder cancer	0.000105	0.000617	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—MTHFR—urinary bladder cancer	0.000104	0.000613	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—EGFR—urinary bladder cancer	0.000104	0.000612	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—NCOR1—urinary bladder cancer	0.000104	0.000609	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—GSTM1—urinary bladder cancer	0.000104	0.000609	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—HPGDS—urinary bladder cancer	0.000103	0.000604	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—ENO2—urinary bladder cancer	0.000103	0.000604	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—TYMP—urinary bladder cancer	0.000103	0.000604	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—GSTT1—urinary bladder cancer	9.95e-05	0.000586	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—CYP4B1—urinary bladder cancer	9.92e-05	0.000584	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—GPX1—urinary bladder cancer	9.91e-05	0.000584	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—TNF—urinary bladder cancer	9.91e-05	0.000583	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—KRAS—urinary bladder cancer	9.83e-05	0.000578	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—ERCC2—urinary bladder cancer	9.73e-05	0.000573	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—HRAS—urinary bladder cancer	9.51e-05	0.00056	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—SLC19A1—urinary bladder cancer	9.36e-05	0.000551	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—NAT2—urinary bladder cancer	9.28e-05	0.000546	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—MTHFR—urinary bladder cancer	9.15e-05	0.000539	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—PRSS3—urinary bladder cancer	9.13e-05	0.000537	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—PPARG—urinary bladder cancer	8.44e-05	0.000497	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—HRAS—urinary bladder cancer	8.35e-05	0.000492	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	8.3e-05	0.000489	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—NQO1—urinary bladder cancer	8.27e-05	0.000487	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—CREBBP—urinary bladder cancer	8.11e-05	0.000477	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—RRM2—urinary bladder cancer	8.01e-05	0.000471	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	7.87e-05	0.000463	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—NAT1—urinary bladder cancer	7.87e-05	0.000463	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—PPARG—urinary bladder cancer	7.42e-05	0.000437	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—HPGDS—urinary bladder cancer	7.42e-05	0.000437	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—ENO2—urinary bladder cancer	7.42e-05	0.000437	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—TYMP—urinary bladder cancer	7.3e-05	0.000429	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	7.2e-05	0.000424	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—GSTT1—urinary bladder cancer	7.19e-05	0.000424	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—CREBBP—urinary bladder cancer	7.13e-05	0.00042	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—GSTP1—urinary bladder cancer	6.9e-05	0.000406	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—PTGS2—urinary bladder cancer	6.64e-05	0.000391	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—NAT2—urinary bladder cancer	6.6e-05	0.000388	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	6.48e-05	0.000382	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—TYMS—urinary bladder cancer	6.41e-05	0.000378	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—GSTM1—urinary bladder cancer	6.34e-05	0.000373	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—NCOR1—urinary bladder cancer	6.34e-05	0.000373	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	6.12e-05	0.00036	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—GPX1—urinary bladder cancer	6.07e-05	0.000357	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—NQO1—urinary bladder cancer	5.98e-05	0.000352	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	5.97e-05	0.000351	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—ERCC2—urinary bladder cancer	5.96e-05	0.000351	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—PTGS2—urinary bladder cancer	5.84e-05	0.000344	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—PTEN—urinary bladder cancer	5.79e-05	0.000341	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—RRM2—urinary bladder cancer	5.7e-05	0.000335	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—MTHFR—urinary bladder cancer	5.6e-05	0.00033	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—EP300—urinary bladder cancer	5.52e-05	0.000325	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—ENO2—urinary bladder cancer	5.27e-05	0.00031	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	5.27e-05	0.00031	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	5.12e-05	0.000301	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—PTEN—urinary bladder cancer	5.09e-05	0.0003	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—GSTP1—urinary bladder cancer	4.99e-05	0.000294	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—EP300—urinary bladder cancer	4.85e-05	0.000286	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—TYMP—urinary bladder cancer	4.77e-05	0.000281	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—TYMS—urinary bladder cancer	4.64e-05	0.000273	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—GSTM1—urinary bladder cancer	4.58e-05	0.00027	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—NCOR1—urinary bladder cancer	4.58e-05	0.00027	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—PPARG—urinary bladder cancer	4.54e-05	0.000267	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—GPX1—urinary bladder cancer	4.39e-05	0.000258	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—CREBBP—urinary bladder cancer	4.36e-05	0.000257	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—NAT2—urinary bladder cancer	4.31e-05	0.000254	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—ERCC2—urinary bladder cancer	4.31e-05	0.000254	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—NQO1—urinary bladder cancer	4.25e-05	0.00025	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—MTHFR—urinary bladder cancer	4.05e-05	0.000238	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—RRM2—urinary bladder cancer	3.72e-05	0.000219	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—PTGS2—urinary bladder cancer	3.57e-05	0.00021	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	3.55e-05	0.000209	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—ENO2—urinary bladder cancer	3.45e-05	0.000203	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	3.45e-05	0.000203	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	3.34e-05	0.000197	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—TYMS—urinary bladder cancer	3.3e-05	0.000194	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—PPARG—urinary bladder cancer	3.28e-05	0.000193	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	3.26e-05	0.000192	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	3.26e-05	0.000192	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—CREBBP—urinary bladder cancer	3.15e-05	0.000186	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—GPX1—urinary bladder cancer	3.12e-05	0.000184	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—PTEN—urinary bladder cancer	3.12e-05	0.000183	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	3.06e-05	0.00018	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—EP300—urinary bladder cancer	2.97e-05	0.000175	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	2.88e-05	0.00017	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—NQO1—urinary bladder cancer	2.78e-05	0.000164	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—PTGS2—urinary bladder cancer	2.58e-05	0.000152	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—PPARG—urinary bladder cancer	2.34e-05	0.000137	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	2.32e-05	0.000136	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—PTEN—urinary bladder cancer	2.25e-05	0.000133	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	2.24e-05	0.000132	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—TYMS—urinary bladder cancer	2.16e-05	0.000127	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—EP300—urinary bladder cancer	2.15e-05	0.000126	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	2.13e-05	0.000125	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	2.13e-05	0.000125	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—GPX1—urinary bladder cancer	2.04e-05	0.00012	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	2e-05	0.000118	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	1.88e-05	0.000111	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	1.84e-05	0.000108	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—PTEN—urinary bladder cancer	1.6e-05	9.43e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—EP300—urinary bladder cancer	1.53e-05	8.99e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—PPARG—urinary bladder cancer	1.53e-05	8.99e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	1.47e-05	8.63e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	1.2e-05	7.07e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—PTEN—urinary bladder cancer	1.05e-05	6.17e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—EP300—urinary bladder cancer	9.99e-06	5.88e-05	CbGpPWpGaD
